3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Skin Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booij, J; Boot, E; van Amelsvoort, T; van Eeden, S | 1 |
| Bombardieri, E; Chiti, A; Gasparini, M; Maffioli, L | 1 |
| Baldini, MT; Buraggi, GL; Cascinelli, N; Castellani, MR; Gasparini, M; Maffioli, L; Mascheroni, L; Mongioj, V; Seregni, E | 1 |
| Bida, B; Henker, C; Markwardt, J; Schlag, P | 1 |
| Bohuslavizki, KH; Brenner, W; Henze, E; Kampen, WU; Klomp, HJ; Szonn, B | 1 |
2 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Skin Neoplasms
| Article | Year |
|---|---|
Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1].
Topics: Benzamides; Contrast Media; Dopamine Antagonists; Humans; Indium Radioisotopes; Iodine Radioisotopes; Melanoma; Pyrrolidines; Radioimmunodetection; Sensitivity and Specificity; Skin Neoplasms; Somatostatin | 1994 |
Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Contrast Media; Dopamine Antagonists; Evaluation Studies as Topic; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pyrrolidines; Radiation Dosage; Skin Neoplasms; Tomography, Emission-Computed, Single-Photon | 1994 |
3 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Skin Neoplasms
| Article | Year |
|---|---|
Unexpected detection of nodular melanoma of the skin on the scalp by I-123 IBZM brain SPECT.
Topics: Benzamides; Brain; Female; Head and Neck Neoplasms; Humans; Incidental Findings; Melanoma; Pyrrolidines; Scalp; Skin Neoplasms; Tomography, Emission-Computed, Single-Photon; Young Adult | 2011 |
[Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
Topics: Benzamides; Brain Neoplasms; Dopamine Antagonists; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Magnetic Resonance Imaging; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Pyrrolidines; Radionuclide Imaging; Skin Neoplasms; Tomography, X-Ray Computed | 1997 |
Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
Topics: Adult; Aged; Benzamides; Evaluation Studies as Topic; Female; Humans; Male; Melanoma; Middle Aged; Prospective Studies; Pyrrolidines; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thallium Radioisotopes | 1999 |